Logo-ijbsm
Int J Basic Sci Med. 2017;2(1): 20-24. doi: 10.15171/ijbsm.2017.05

Original article

Evaluation of IL-4, IL-17, and IFN-γ Levels in PatientsWith Breast Cancer

Mina Rohani Borj 1, Ali Reza Andalib 2, Abbas Mohammadi 3, Seyed Mojtba Hoseiniharouni 4, Hossein Pourghadamyari 5, Hakim Azizi 6, Taghi Golmahammadi 5, Kamran Moghaddas Ghahfarokhy 7 *

Cited by CrossRef: 7


1- Lee C. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids. Biochemical Pharmacology. 2018;158:261 [Crossref]
2- Ali E, Masri M, Siddig E, Ahmed A, Muneer M, Mohamed N, Edris A. Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions. BMC Res Notes. 2020;13(1) [Crossref]
3- Jørgensen N, Sayed A, Jeppesen H, Persson G, Weisdorf I, Funck T, Hviid T. Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation. IJMS. 2020;21(12):4307 [Crossref]
4- Jain M, Mishra A, Yadav V, Shyam H, Kumar S, Mishra S, Ramakant P. Long-Term Yogic Intervention Improves Symptomatic Scale and Quality of Life by Reducing Inflammatory Cytokines and Oxidative Stress in Breast Cancer Patients Undergoing Chemotherapy and/or Radiotherapy: A Randomized Control Study. 2023; [Crossref]
5- Bel’skaya L, Loginova A, Sarf E. Pro-Inflammatory and Anti-Inflammatory Salivary Cytokines in Breast Cancer: Relationship with Clinicopathological Characteristics of the Tumor. CIMB. 2022;44(10):4676 [Crossref]
6- Popović M, Dedić Plavetić N, Vrbanec D, Marušić Z, Mijatović D, Kulić A. Interleukin 17 in early invasive breast cancer. Front Oncol. 2023;13 [Crossref]
7- de Sousa Pereira N, Motoori-Fernandes C, Banin-Hirata B, Vitiello G, de Oliveira C, Amarante M, Watanabe M. Interferon-gamma plasma levels and presence of mouse mammary tumor virus-like env gene: Implications on the pathogenesis of breast cancer. Cytokine. 2023;169:156299 [Crossref]
8- Ghasemi-Dehkordi P, Doosti A, Jami M. The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice. 3 Biotech. 2019;9(7) [Crossref]
9- Bel'skaya L, Sarf E, Kosenok V. Indicators of L-arginine metabolism in saliva: A focus on breast cancer. Journal of Oral Biosciences. 2021;63(1):52 [Crossref]
10- Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. International Reviews of Immunology. 2021;40(3):197 [Crossref]
Indexing Info:
Member of: